Predictive markers for MGMT promoter methylation in glioblastomas
- PMID: 30673883
- DOI: 10.1007/s10143-018-01061-5
Predictive markers for MGMT promoter methylation in glioblastomas
Abstract
The promoter methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) gene has been described as the most important predictor of chemotherapeutic response and patients' survival in glioblastomas (GBs). Therefore, prediction of the MGMT promoter methylation status by imaging would help to preoperatively decide the overall treatment strategy as well as surgical strategy. This study aimed to detect imaging parameters to predict MGMT promoter methylation in GBs by using a commercially available software. We investigated three imaging features (ring enhancement, tumor location, and laterality) and apparent diffusion coefficient (ADC) parameters in 48 newly diagnosed GBs treated at Keio University Hospital in 2006 or later. For ADC, texture analyses were performed. Regions of interest (ROIs) were drawn manually with reference to contrast-enhanced areas, excluding necrotic and cystic regions. Mean ADC value and ADC histogram parameters, including kurtosis, skewness, and entropy, were compared with MGMT promoter methylation. Each parameter was evaluated to determine correlation with MGMT promoter methylation, and the parameters with significant associations with the methylation status were correlated with the MGMT-positive cell ratio determined by immunohistochemistry (IHC) analysis. The mean ADC value and ADC entropy were significantly associated with MGMT promoter methylation. The combination of mean ADC value and ADC entropy predicted MGMT promoter methylation, with a PPV of 81.2% and specificity of 88.9%. The mean ADC value and ADC entropy were negatively correlated with the MGMT-positive cell ratio in the IHC analysis. This study demonstrated that texture analyses of ADC histograms in GBs were predictive of MGMT promoter methylation.
Keywords: ADC; Glioblastoma; MGMT; Texture analysis.
Similar articles
-
Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis.BMC Cancer. 2018 Feb 21;18(1):215. doi: 10.1186/s12885-018-4114-2. BMC Cancer. 2018. PMID: 29467012 Free PMC article.
-
Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme.J Magn Reson Imaging. 2013 Feb;37(2):351-8. doi: 10.1002/jmri.23838. Epub 2012 Sep 28. J Magn Reson Imaging. 2013. PMID: 23023975
-
Incremental Prognostic Value of ADC Histogram Analysis over MGMT Promoter Methylation Status in Patients with Glioblastoma.Radiology. 2016 Oct;281(1):175-84. doi: 10.1148/radiol.2016151913. Epub 2016 Apr 27. Radiology. 2016. PMID: 27120357
-
Clinically Relevant Imaging Features for MGMT Promoter Methylation in Multiple Glioblastoma Studies: A Systematic Review and Meta-Analysis.AJNR Am J Neuroradiol. 2018 Aug;39(8):1439-1445. doi: 10.3174/ajnr.A5711. Epub 2018 Jul 12. AJNR Am J Neuroradiol. 2018. PMID: 30002055 Free PMC article.
-
Association between response to primary treatments and MGMT status in glioblastoma.Expert Rev Anticancer Ther. 2008 Nov;8(11):1781-6. doi: 10.1586/14737140.8.11.1781. Expert Rev Anticancer Ther. 2008. PMID: 18983238 Review.
Cited by
-
Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives.Biomark Res. 2023 Mar 29;11(1):35. doi: 10.1186/s40364-023-00476-7. Biomark Res. 2023. PMID: 36991494 Free PMC article. Review.
-
Advanced Distance-Resolved Evaluation of the Perienhancing Tumor Areas with FLAIR Hyperintensity Indicates Different ADC Profiles by MGMT Promoter Methylation Status in Glioblastoma.AJNR Am J Neuroradiol. 2025 Feb 3;46(2):302-310. doi: 10.3174/ajnr.A8493. AJNR Am J Neuroradiol. 2025. PMID: 39848779
-
Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance.Int J Mol Sci. 2020 Aug 6;21(16):5631. doi: 10.3390/ijms21165631. Int J Mol Sci. 2020. PMID: 32781585 Free PMC article. Review.
-
Clinical strategies to manage adult glioblastoma patients without MGMT hypermethylation.J Cancer. 2022 Jan 1;13(1):354-363. doi: 10.7150/jca.63595. eCollection 2022. J Cancer. 2022. PMID: 34976195 Free PMC article. Review.
-
Texture Analysis in Brain Tumor MR Imaging.Magn Reson Med Sci. 2022 Mar 1;21(1):95-109. doi: 10.2463/mrms.rev.2020-0159. Epub 2021 Mar 10. Magn Reson Med Sci. 2022. PMID: 33692222 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials